Ireland
--:--IST
Latest
Clinical Trials in the USA / NCT07858214
Enrolling by invitation Observational

Measurement of Ocular Microtremor With the iTremor Device in a Diverse US Cohort

NCT07858214 · tracked via the Priya Life Science USA tracker
Sponsor
Head Diagnostics
Phase
Observational
Started
2026-09-28
Last updated
2026-10-05

Condition(s) studied

All ConditionsAll

Study summary

To evaluate the reliability of using the iTremor device to accurately measure Ocular Microtremor (OMT) across a diverse cohort, representative of the US population, with a view to establishing this as a standard measurement tool for OMT.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion criteria: * Adults 18 years of age or older. * Normal or corrected to normal bilateral vision. * Ability to sit and look forward for periods of at least 5 seconds. * Communicate in English with the study team. Exclusion criteria: * Visible or known injuries to eye or eye socket. * Non-intact periorbital skin * Oculomotor palsy * Strabismus (cross-eyedness) / impaired ocular mobility * Inability to refrain from alcohol, cannabis or other recreational drugs for 24 hours prior to study visit. * Inability or unwillingness to remove scleral contact lenses or glasses for the length of the study visit. * Conditions, not explicitly described, identified by clinical exam, which would make achieving a measurement impractical or uncomfortable for the participant.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Emory University Atlanta Georgia
Massachusetts Institute of Technology Cambridge Massachusetts

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07858214 on ClinicalTrials.gov ↗ ← All trials in the USA